サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1118183

世界の骨肉腫の治療法市場：考察と予測 (2028年まで)

Global Bone Cancer Treatment Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 111 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の骨肉腫の治療法市場：考察と予測 (2028年まで)
出版日: 2022年08月24日
発行: QYResearch
ページ情報: 英文 111 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、骨肉腫の治療法 (Bone Cancer Treatment) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の骨肉腫の治療法の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Radiation Therapy
    • Chemotherapy
    • Surgical Treatments
    • Cryosurgery
    • Drugs
  • 市場：アプリケーション別
    • 世界の骨肉腫の治療法の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Diffuse Bone Cancer
    • Nodular Bone Cancer
    • Necrotizing Bone Cancer
    • Other
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の骨肉腫の治療法の市場展望 (2017-2028)
  • 骨肉腫の治療法の市場成長トレンド：地域別
    • 骨肉腫の治療法 市場規模：地域別: 2017 VS 2021 VS 2028
    • 骨肉腫の治療法の市場規模実績：地域別 (2017-2022)
    • 骨肉腫の治療法の市場規模予測：地域別 (2023-2028)
  • 骨肉腫の治療法 市場動向
    • 骨肉腫の治療法 業界動向
    • 骨肉腫の治療法 市場の促進要因
    • 骨肉腫の治療法 市場の課題
    • 骨肉腫の治療法 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の骨肉腫の治療法の上位企業：収益別
    • 世界の骨肉腫の治療法の上位企業：収益別 (2017-2022)
    • 世界の骨肉腫の治療法の収益シェア：企業別 (2017-2022)
  • 世界の骨肉腫の治療法の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：骨肉腫の治療法の収益
  • 世界の骨肉腫の治療法 市場集中度
    • 世界の骨肉腫の治療法 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 骨肉腫の治療法の収益 2021
  • 骨肉腫の治療法の主要企業の本社および事業エリア
  • 主要企業 骨肉腫の治療法の製品ソリューションおよびサービス
  • 市場参入時期： 骨肉腫の治療法 市場
  • M&A, 拡張計画

第4章 骨肉腫の治療法 内訳データ：タイプ別

  • 世界の骨肉腫の治療法の市場規模実績：タイプ別 (2017-2022)
  • 世界の骨肉腫の治療法の市場規模予測：タイプ別 (2023-2028)

第5章 骨肉腫の治療法 内訳データ：アプリケーション別

  • 世界の骨肉腫の治療法の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の骨肉腫の治療法の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の骨肉腫の治療法 市場規模 (2017-2028)
  • 北米の骨肉腫の治療法 市場規模：タイプ別
    • 北米の骨肉腫の治療法 市場規模：タイプ別 (2017-2022)
    • 北米の骨肉腫の治療法 市場規模：タイプ別 (2023-2028)
    • 北米の骨肉腫の治療法の市場シェア：タイプ別 (2017-2028)
  • 北米の骨肉腫の治療法 市場規模：アプリケーション別
    • 北米の骨肉腫の治療法 市場規模：アプリケーション別 (2017-2022)
    • 北米の骨肉腫の治療法 市場規模：アプリケーション別 (2023-2028)
    • 北米の骨肉腫の治療法の市場シェア：アプリケーション別 (2017-2028)
  • 北米の骨肉腫の治療法 市場規模：国別
    • 北米の骨肉腫の治療法 市場規模：国別 (2017-2022)
    • 北米の骨肉腫の治療法 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の骨肉腫の治療法 市場規模 (2017-2028)
  • 欧州の骨肉腫の治療法 市場規模：タイプ別
    • 欧州の骨肉腫の治療法 市場規模：タイプ別 (2017-2022)
    • 欧州の骨肉腫の治療法 市場規模：タイプ別 (2023-2028)
    • 欧州の骨肉腫の治療法の市場シェア：タイプ別 (2017-2028)
  • 欧州の骨肉腫の治療法 市場規模：アプリケーション別
    • 欧州の骨肉腫の治療法 市場規模：アプリケーション別 (2017-2022)
    • 欧州の骨肉腫の治療法 市場規模：アプリケーション別 (2023-2028)
    • 欧州の骨肉腫の治療法の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の骨肉腫の治療法 市場規模：国別
    • 欧州の骨肉腫の治療法 市場規模：国別 (2017-2022)
    • 欧州の骨肉腫の治療法 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 骨肉腫の治療法 市場規模 (2017-2028)
  • アジア太平洋地域 骨肉腫の治療法 市場規模：タイプ別
    • アジア太平洋地域 骨肉腫の治療法 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 骨肉腫の治療法 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 骨肉腫の治療法の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 骨肉腫の治療法 市場規模：アプリケーション別
    • アジア太平洋地域 骨肉腫の治療法 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 骨肉腫の治療法 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 骨肉腫の治療法の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 骨肉腫の治療法 市場規模：地域別
    • アジア太平洋地域 骨肉腫の治療法 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 骨肉腫の治療法 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの骨肉腫の治療法 市場規模 (2017-2028)
  • ラテンアメリカの骨肉腫の治療法 市場規模：タイプ別
    • ラテンアメリカの骨肉腫の治療法 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの骨肉腫の治療法 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの骨肉腫の治療法の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの骨肉腫の治療法 市場規模：アプリケーション別
    • ラテンアメリカの骨肉腫の治療法 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの骨肉腫の治療法 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの骨肉腫の治療法の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの骨肉腫の治療法 市場規模：国別
    • ラテンアメリカの骨肉腫の治療法 市場規模：国別 (2017-2022)
    • ラテンアメリカの骨肉腫の治療法 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの骨肉腫の治療法 市場規模 (2017-2028)
  • 中東・アフリカの骨肉腫の治療法 市場規模：タイプ別
    • 中東・アフリカの骨肉腫の治療法 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの骨肉腫の治療法 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの骨肉腫の治療法の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの骨肉腫の治療法 市場規模：アプリケーション別
    • 中東・アフリカの骨肉腫の治療法 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの骨肉腫の治療法 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの骨肉腫の治療法の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの骨肉腫の治療法 市場規模：国別
    • 中東・アフリカの骨肉腫の治療法 市場規模：国別 (2017-2022)
    • 中東・アフリカの骨肉腫の治療法 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Bayer AG
  • Amgen
  • Novartis AG
  • Pfizer
  • AstraZeneca
  • Dr. Reddy's Laboratories (DRL)
  • Actavis
  • Bristol-Myers Squibb
  • Celgene Corporation
  • Eli Lilly
  • Roche
  • GlaxoSmithKline
  • Sanofi
  • Amneal Pharmaceuticals LLC
  • Baxter International
  • BoehringerIngelheim
  • Fresenius Kabi
  • Jubilant Cadista Pharmaceuticals
  • Mylan Pharmaceuticals
  • Perrigo Company
  • Roxane Laboratories
  • Sandoz
  • Henlius Biotech
  • Teva Pharmaceuticals USA
  • West-Ward Pharmaceuticals
  • Zydus Pharmaceuticals (Cadila Healthcare)

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Bone Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Radiation Therapy
  • Table 3. Key Players of Chemotherapy
  • Table 4. Key Players of Surgical Treatments
  • Table 5. Key Players of Cryosurgery
  • Table 6. Key Players of Drugs
  • Table 7. Global Bone Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 8. Global Bone Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 9. Global Bone Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 10. Global Bone Cancer Treatment Market Share by Region (2017-2022)
  • Table 11. Global Bone Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 12. Global Bone Cancer Treatment Market Share by Region (2023-2028)
  • Table 13. Bone Cancer Treatment Market Trends
  • Table 14. Bone Cancer Treatment Market Drivers
  • Table 15. Bone Cancer Treatment Market Challenges
  • Table 16. Bone Cancer Treatment Market Restraints
  • Table 17. Global Bone Cancer Treatment Revenue by Players (2017-2022) & (US$ Million)
  • Table 18. Global Bone Cancer Treatment Revenue Share by Players (2017-2022)
  • Table 19. Global Top Bone Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bone Cancer Treatment as of 2021)
  • Table 20. Ranking of Global Top Bone Cancer Treatment Companies by Revenue (US$ Million) in 2021
  • Table 21. Global 5 Largest Players Market Share by Bone Cancer Treatment Revenue (CR5 and HHI) & (2017-2022)
  • Table 22. Key Players Headquarters and Area Served
  • Table 23. Key Players Bone Cancer Treatment Product Solution and Service
  • Table 24. Date of Enter into Bone Cancer Treatment Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Bone Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 27. Global Bone Cancer Treatment Revenue Market Share by Type (2017-2022)
  • Table 28. Global Bone Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 29. Global Bone Cancer Treatment Revenue Market Share by Type (2023-2028)
  • Table 30. Global Bone Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 31. Global Bone Cancer Treatment Revenue Share by Application (2017-2022)
  • Table 32. Global Bone Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 33. Global Bone Cancer Treatment Revenue Share by Application (2023-2028)
  • Table 34. North America Bone Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 35. North America Bone Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 36. North America Bone Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 37. North America Bone Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 38. North America Bone Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 39. North America Bone Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 40. Europe Bone Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 41. Europe Bone Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 42. Europe Bone Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 43. Europe Bone Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 44. Europe Bone Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 45. Europe Bone Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Bone Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Bone Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Bone Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Bone Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 50. Asia Pacific Bone Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
  • Table 51. Asia Pacific Bone Cancer Treatment Market Size by Region (2023-2028) & (US$ Million)
  • Table 52. Latin America Bone Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 53. Latin America Bone Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 54. Latin America Bone Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 55. Latin America Bone Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 56. Latin America Bone Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 57. Latin America Bone Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Bone Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Bone Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Bone Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Bone Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
  • Table 62. Middle East and Africa Bone Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
  • Table 63. Middle East and Africa Bone Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
  • Table 64. Bayer AG Company Details
  • Table 65. Bayer AG Business Overview
  • Table 66. Bayer AG Bone Cancer Treatment Product
  • Table 67. Bayer AG Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 68. Bayer AG Recent Developments
  • Table 69. Amgen Company Details
  • Table 70. Amgen Business Overview
  • Table 71. Amgen Bone Cancer Treatment Product
  • Table 72. Amgen Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 73. Amgen Recent Developments
  • Table 74. Novartis AG Company Details
  • Table 75. Novartis AG Business Overview
  • Table 76. Novartis AG Bone Cancer Treatment Product
  • Table 77. Novartis AG Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 78. Novartis AG Recent Developments
  • Table 79. Pfizer Company Details
  • Table 80. Pfizer Business Overview
  • Table 81. Pfizer Bone Cancer Treatment Product
  • Table 82. Pfizer Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 83. Pfizer Recent Developments
  • Table 84. AstraZeneca Company Details
  • Table 85. AstraZeneca Business Overview
  • Table 86. AstraZeneca Bone Cancer Treatment Product
  • Table 87. AstraZeneca Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 88. AstraZeneca Recent Developments
  • Table 89. Dr. Reddy's Laboratories (DRL) Company Details
  • Table 90. Dr. Reddy's Laboratories (DRL) Business Overview
  • Table 91. Dr. Reddy's Laboratories (DRL) Bone Cancer Treatment Product
  • Table 92. Dr. Reddy's Laboratories (DRL) Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 93. Dr. Reddy's Laboratories (DRL) Recent Developments
  • Table 94. Actavis Company Details
  • Table 95. Actavis Business Overview
  • Table 96. Actavis Bone Cancer Treatment Product
  • Table 97. Actavis Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 98. Actavis Recent Developments
  • Table 99. Bristol-Myers Squibb Company Details
  • Table 100. Bristol-Myers Squibb Business Overview
  • Table 101. Bristol-Myers Squibb Bone Cancer Treatment Product
  • Table 102. Bristol-Myers Squibb Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 103. Bristol-Myers Squibb Recent Developments
  • Table 104. Celgene Corporation Company Details
  • Table 105. Celgene Corporation Business Overview
  • Table 106. Celgene Corporation Bone Cancer Treatment Product
  • Table 107. Celgene Corporation Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 108. Celgene Corporation Recent Developments
  • Table 109. Eli Lilly Company Details
  • Table 110. Eli Lilly Business Overview
  • Table 111. Eli Lilly Bone Cancer Treatment Product
  • Table 112. Eli Lilly Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 113. Eli Lilly Recent Developments
  • Table 114. Roche Company Details
  • Table 115. Roche Business Overview
  • Table 116. Roche Bone Cancer Treatment Product
  • Table 117. Roche Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 118. Roche Recent Developments
  • Table 119. GlaxoSmithKline Company Details
  • Table 120. GlaxoSmithKline Business Overview
  • Table 121. GlaxoSmithKline Bone Cancer Treatment Product
  • Table 122. GlaxoSmithKline Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 123. GlaxoSmithKline Recent Developments
  • Table 124. Sanofi Company Details
  • Table 125. Sanofi Business Overview
  • Table 126. Sanofi Bone Cancer Treatment Product
  • Table 127. Sanofi Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 128. Sanofi Recent Developments
  • Table 129. Amneal Pharmaceuticals LLC Company Details
  • Table 130. Amneal Pharmaceuticals LLC Business Overview
  • Table 131. Amneal Pharmaceuticals LLC Bone Cancer Treatment Product
  • Table 132. Amneal Pharmaceuticals LLC Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 133. Amneal Pharmaceuticals LLC Recent Developments
  • Table 134. Baxter International Company Details
  • Table 135. Baxter International Business Overview
  • Table 136. Baxter International Bone Cancer Treatment Product
  • Table 137. Baxter International Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 138. Baxter International Recent Developments
  • Table 139. BoehringerIngelheim Company Details
  • Table 140. BoehringerIngelheim Business Overview
  • Table 141. BoehringerIngelheim Bone Cancer Treatment Product
  • Table 142. BoehringerIngelheim Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 143. BoehringerIngelheim Recent Developments
  • Table 144. Fresenius Kabi Company Details
  • Table 145. Fresenius Kabi Business Overview
  • Table 146. Fresenius Kabi Bone Cancer Treatment Product
  • Table 147. Fresenius Kabi Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 148. Fresenius Kabi Recent Developments
  • Table 149. Jubilant Cadista Pharmaceuticals Company Details
  • Table 150. Jubilant Cadista Pharmaceuticals Business Overview
  • Table 151. Jubilant Cadista Pharmaceuticals Bone Cancer Treatment Product
  • Table 152. Jubilant Cadista Pharmaceuticals Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 153. Jubilant Cadista Pharmaceuticals Recent Developments
  • Table 154. Mylan Pharmaceuticals Company Details
  • Table 155. Mylan Pharmaceuticals Business Overview
  • Table 156. Mylan Pharmaceuticals Bone Cancer Treatment Product
  • Table 157. Mylan Pharmaceuticals Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 158. Mylan Pharmaceuticals Recent Developments
  • Table 159. Perrigo Company Company Details
  • Table 160. Perrigo Company Business Overview
  • Table 161. Perrigo Company Bone Cancer Treatment Product
  • Table 162. Perrigo Company Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 163. Perrigo Company Recent Developments
  • Table 164. Roxane Laboratories Company Details
  • Table 165. Roxane Laboratories Business Overview
  • Table 166. Roxane Laboratories Bone Cancer Treatment Product
  • Table 167. Roxane Laboratories Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 168. Roxane Laboratories Recent Developments
  • Table 169. Sandoz Company Details
  • Table 170. Sandoz Business Overview
  • Table 171. Sandoz Bone Cancer Treatment Product
  • Table 172. Sandoz Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 173. Sandoz Recent Developments
  • Table 174. Henlius Biotech Company Details
  • Table 175. Henlius Biotech Business Overview
  • Table 176. Henlius Biotech Bone Cancer Treatment Product
  • Table 177. Henlius Biotech Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 178. Henlius Biotech Recent Developments
  • Table 179. Teva Pharmaceuticals USA Company Details
  • Table 180. Teva Pharmaceuticals USA Business Overview
  • Table 181. Teva Pharmaceuticals USA Bone Cancer Treatment Product
  • Table 182. Teva Pharmaceuticals USA Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 183. Teva Pharmaceuticals USA Recent Developments
  • Table 184. West-Ward Pharmaceuticals Company Details
  • Table 185. West-Ward Pharmaceuticals Business Overview
  • Table 186. West-Ward Pharmaceuticals Bone Cancer Treatment Product
  • Table 187. West-Ward Pharmaceuticals Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 188. West-Ward Pharmaceuticals Recent Developments
  • Table 189. Zydus Pharmaceuticals (Cadila Healthcare) Company Details
  • Table 190. Zydus Pharmaceuticals (Cadila Healthcare) Business Overview
  • Table 191. Zydus Pharmaceuticals (Cadila Healthcare) Bone Cancer Treatment Product
  • Table 192. Zydus Pharmaceuticals (Cadila Healthcare) Revenue in Bone Cancer Treatment Business (2017-2022) & (US$ Million)
  • Table 193. Zydus Pharmaceuticals (Cadila Healthcare) Recent Developments
  • Table 194. Research Programs/Design for This Report
  • Table 195. Key Data Information from Secondary Sources
  • Table 196. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Bone Cancer Treatment Market Share by Type: 2021 VS 2028
  • Figure 2. Radiation Therapy Features
  • Figure 3. Chemotherapy Features
  • Figure 4. Surgical Treatments Features
  • Figure 5. Cryosurgery Features
  • Figure 6. Drugs Features
  • Figure 7. Global Bone Cancer Treatment Market Share by Application: 2021 VS 2028
  • Figure 8. Diffuse Bone Cancer Case Studies
  • Figure 9. Nodular Bone Cancer Case Studies
  • Figure 10. Necrotizing Bone Cancer Case Studies
  • Figure 11. Other Case Studies
  • Figure 12. Bone Cancer Treatment Report Years Considered
  • Figure 13. Global Bone Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 14. Global Bone Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 15. Global Bone Cancer Treatment Market Share by Region: 2021 VS 2028
  • Figure 16. Global Bone Cancer Treatment Market Share by Players in 2021
  • Figure 17. Global Top Bone Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bone Cancer Treatment as of 2021)
  • Figure 18. The Top 10 and 5 Players Market Share by Bone Cancer Treatment Revenue in 2021
  • Figure 19. North America Bone Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 20. North America Bone Cancer Treatment Market Size Market Share by Type (2017-2028)
  • Figure 21. North America Bone Cancer Treatment Market Size Market Share by Application (2017-2028)
  • Figure 22. North America Bone Cancer Treatment Market Size Share by Country (2017-2028)
  • Figure 23. United States Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Canada Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. Europe Bone Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 26. Europe Bone Cancer Treatment Market Size Market Share by Type (2017-2028)
  • Figure 27. Europe Bone Cancer Treatment Market Size Market Share by Application (2017-2028)
  • Figure 28. Europe Bone Cancer Treatment Market Size Share by Country (2017-2028)
  • Figure 29. Germany Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. France Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. U.K. Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Italy Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Russia Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Nordic Countries Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Asia-Pacific Bone Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 36. Asia Pacific Bone Cancer Treatment Market Size Market Share by Type (2017-2028)
  • Figure 37. Asia Pacific Bone Cancer Treatment Market Size Market Share by Application (2017-2028)
  • Figure 38. Asia Pacific Bone Cancer Treatment Market Size Share by Region (2017-2028)
  • Figure 39. China Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Japan Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. South Korea Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. Southeast Asia Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. India Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Australia Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 45. Latin America Bone Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 46. Latin America Bone Cancer Treatment Market Size Market Share by Type (2017-2028)
  • Figure 47. Latin America Bone Cancer Treatment Market Size Market Share by Application (2017-2028)
  • Figure 48. Latin America Bone Cancer Treatment Market Size Share by Country (2017-2028)
  • Figure 49. Mexico Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Brazil Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 51. Middle East & Africa Bone Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
  • Figure 52. Middle East and Africa Bone Cancer Treatment Market Size Market Share by Type (2017-2028)
  • Figure 53. Middle East and Africa Bone Cancer Treatment Market Size Market Share by Application (2017-2028)
  • Figure 54. Middle East and Africa Bone Cancer Treatment Market Size Share by Country (2017-2028)
  • Figure 55. Turkey Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Saudi Arabia Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 57. UAE Bone Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 58. Bayer AG Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 59. Amgen Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 60. Novartis AG Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 61. Pfizer Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 62. AstraZeneca Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 63. Dr. Reddy's Laboratories (DRL) Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 64. Actavis Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 66. Celgene Corporation Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 67. Eli Lilly Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 68. Roche Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 69. GlaxoSmithKline Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 70. Sanofi Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 71. Amneal Pharmaceuticals LLC Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 72. Baxter International Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 73. BoehringerIngelheim Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 74. Fresenius Kabi Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 75. Jubilant Cadista Pharmaceuticals Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 76. Mylan Pharmaceuticals Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 77. Perrigo Company Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 78. Roxane Laboratories Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 79. Sandoz Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 80. Henlius Biotech Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 81. Teva Pharmaceuticals USA Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 82. West-Ward Pharmaceuticals Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 83. Zydus Pharmaceuticals (Cadila Healthcare) Revenue Growth Rate in Bone Cancer Treatment Business (2017-2022)
  • Figure 84. Bottom-up and Top-down Approaches for This Report
  • Figure 85. Data Triangulation
  • Figure 86. Key Executives Interviewed
目次

This research report focuses on the Bone Cancer Treatment Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Bone Cancer Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Radiation Therapy
    • 1.2.3 Chemotherapy
    • 1.2.4 Surgical Treatments
    • 1.2.5 Cryosurgery
    • 1.2.6 Drugs
  • 1.3 Market by Application
    • 1.3.1 Global Bone Cancer Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Diffuse Bone Cancer
    • 1.3.3 Nodular Bone Cancer
    • 1.3.4 Necrotizing Bone Cancer
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Bone Cancer Treatment Market Perspective (2017-2028)
  • 2.2 Bone Cancer Treatment Growth Trends by Region
    • 2.2.1 Bone Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Bone Cancer Treatment Historic Market Size by Region (2017-2022)
    • 2.2.3 Bone Cancer Treatment Forecasted Market Size by Region (2023-2028)
  • 2.3 Bone Cancer Treatment Market Dynamics
    • 2.3.1 Bone Cancer Treatment Industry Trends
    • 2.3.2 Bone Cancer Treatment Market Drivers
    • 2.3.3 Bone Cancer Treatment Market Challenges
    • 2.3.4 Bone Cancer Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Bone Cancer Treatment Players by Revenue
    • 3.1.1 Global Top Bone Cancer Treatment Players by Revenue (2017-2022)
    • 3.1.2 Global Bone Cancer Treatment Revenue Market Share by Players (2017-2022)
  • 3.2 Global Bone Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Bone Cancer Treatment Revenue
  • 3.4 Global Bone Cancer Treatment Market Concentration Ratio
    • 3.4.1 Global Bone Cancer Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Bone Cancer Treatment Revenue in 2021
  • 3.5 Bone Cancer Treatment Key Players Head office and Area Served
  • 3.6 Key Players Bone Cancer Treatment Product Solution and Service
  • 3.7 Date of Enter into Bone Cancer Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Bone Cancer Treatment Breakdown Data by Type

  • 4.1 Global Bone Cancer Treatment Historic Market Size by Type (2017-2022)
  • 4.2 Global Bone Cancer Treatment Forecasted Market Size by Type (2023-2028)

5 Bone Cancer Treatment Breakdown Data by Application

  • 5.1 Global Bone Cancer Treatment Historic Market Size by Application (2017-2022)
  • 5.2 Global Bone Cancer Treatment Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Bone Cancer Treatment Market Size (2017-2028)
  • 6.2 North America Bone Cancer Treatment Market Size by Type
    • 6.2.1 North America Bone Cancer Treatment Market Size by Type (2017-2022)
    • 6.2.2 North America Bone Cancer Treatment Market Size by Type (2023-2028)
    • 6.2.3 North America Bone Cancer Treatment Market Share by Type (2017-2028)
  • 6.3 North America Bone Cancer Treatment Market Size by Application
    • 6.3.1 North America Bone Cancer Treatment Market Size by Application (2017-2022)
    • 6.3.2 North America Bone Cancer Treatment Market Size by Application (2023-2028)
    • 6.3.3 North America Bone Cancer Treatment Market Share by Application (2017-2028)
  • 6.4 North America Bone Cancer Treatment Market Size by Country
    • 6.4.1 North America Bone Cancer Treatment Market Size by Country (2017-2022)
    • 6.4.2 North America Bone Cancer Treatment Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Bone Cancer Treatment Market Size (2017-2028)
  • 7.2 Europe Bone Cancer Treatment Market Size by Type
    • 7.2.1 Europe Bone Cancer Treatment Market Size by Type (2017-2022)
    • 7.2.2 Europe Bone Cancer Treatment Market Size by Type (2023-2028)
    • 7.2.3 Europe Bone Cancer Treatment Market Share by Type (2017-2028)
  • 7.3 Europe Bone Cancer Treatment Market Size by Application
    • 7.3.1 Europe Bone Cancer Treatment Market Size by Application (2017-2022)
    • 7.3.2 Europe Bone Cancer Treatment Market Size by Application (2023-2028)
    • 7.3.3 Europe Bone Cancer Treatment Market Share by Application (2017-2028)
  • 7.4 Europe Bone Cancer Treatment Market Size by Country
    • 7.4.1 Europe Bone Cancer Treatment Market Size by Country (2017-2022)
    • 7.4.2 Europe Bone Cancer Treatment Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Bone Cancer Treatment Market Size (2017-2028)
  • 8.2 Asia-Pacific Bone Cancer Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Bone Cancer Treatment Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Bone Cancer Treatment Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Bone Cancer Treatment Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Bone Cancer Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Bone Cancer Treatment Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Bone Cancer Treatment Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Bone Cancer Treatment Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Bone Cancer Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Bone Cancer Treatment Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Bone Cancer Treatment Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Bone Cancer Treatment Market Size (2017-2028)
  • 9.2 Latin America Bone Cancer Treatment Market Size by Type
    • 9.2.1 Latin America Bone Cancer Treatment Market Size by Type (2017-2022)
    • 9.2.2 Latin America Bone Cancer Treatment Market Size by Type (2023-2028)
    • 9.2.3 Latin America Bone Cancer Treatment Market Share by Type (2017-2028)
  • 9.3 Latin America Bone Cancer Treatment Market Size by Application
    • 9.3.1 Latin America Bone Cancer Treatment Market Size by Application (2017-2022)
    • 9.3.2 Latin America Bone Cancer Treatment Market Size by Application (2023-2028)
    • 9.3.3 Latin America Bone Cancer Treatment Market Share by Application (2017-2028)
  • 9.4 Latin America Bone Cancer Treatment Market Size by Country
    • 9.4.1 Latin America Bone Cancer Treatment Market Size by Country (2017-2022)
    • 9.4.2 Latin America Bone Cancer Treatment Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Bone Cancer Treatment Market Size (2017-2028)
  • 10.2 Middle East & Africa Bone Cancer Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Bone Cancer Treatment Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Bone Cancer Treatment Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Bone Cancer Treatment Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Bone Cancer Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Bone Cancer Treatment Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Bone Cancer Treatment Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Bone Cancer Treatment Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Bone Cancer Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Bone Cancer Treatment Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Bone Cancer Treatment Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Bayer AG
    • 11.1.1 Bayer AG Company Details
    • 11.1.2 Bayer AG Business Overview
    • 11.1.3 Bayer AG Bone Cancer Treatment Introduction
    • 11.1.4 Bayer AG Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.1.5 Bayer AG Recent Developments
  • 11.2 Amgen
    • 11.2.1 Amgen Company Details
    • 11.2.2 Amgen Business Overview
    • 11.2.3 Amgen Bone Cancer Treatment Introduction
    • 11.2.4 Amgen Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.2.5 Amgen Recent Developments
  • 11.3 Novartis AG
    • 11.3.1 Novartis AG Company Details
    • 11.3.2 Novartis AG Business Overview
    • 11.3.3 Novartis AG Bone Cancer Treatment Introduction
    • 11.3.4 Novartis AG Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.3.5 Novartis AG Recent Developments
  • 11.4 Pfizer
    • 11.4.1 Pfizer Company Details
    • 11.4.2 Pfizer Business Overview
    • 11.4.3 Pfizer Bone Cancer Treatment Introduction
    • 11.4.4 Pfizer Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.4.5 Pfizer Recent Developments
  • 11.5 AstraZeneca
    • 11.5.1 AstraZeneca Company Details
    • 11.5.2 AstraZeneca Business Overview
    • 11.5.3 AstraZeneca Bone Cancer Treatment Introduction
    • 11.5.4 AstraZeneca Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.5.5 AstraZeneca Recent Developments
  • 11.6 Dr. Reddy's Laboratories (DRL)
    • 11.6.1 Dr. Reddy's Laboratories (DRL) Company Details
    • 11.6.2 Dr. Reddy's Laboratories (DRL) Business Overview
    • 11.6.3 Dr. Reddy's Laboratories (DRL) Bone Cancer Treatment Introduction
    • 11.6.4 Dr. Reddy's Laboratories (DRL) Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.6.5 Dr. Reddy's Laboratories (DRL) Recent Developments
  • 11.7 Actavis
    • 11.7.1 Actavis Company Details
    • 11.7.2 Actavis Business Overview
    • 11.7.3 Actavis Bone Cancer Treatment Introduction
    • 11.7.4 Actavis Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.7.5 Actavis Recent Developments
  • 11.8 Bristol-Myers Squibb
    • 11.8.1 Bristol-Myers Squibb Company Details
    • 11.8.2 Bristol-Myers Squibb Business Overview
    • 11.8.3 Bristol-Myers Squibb Bone Cancer Treatment Introduction
    • 11.8.4 Bristol-Myers Squibb Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.8.5 Bristol-Myers Squibb Recent Developments
  • 11.9 Celgene Corporation
    • 11.9.1 Celgene Corporation Company Details
    • 11.9.2 Celgene Corporation Business Overview
    • 11.9.3 Celgene Corporation Bone Cancer Treatment Introduction
    • 11.9.4 Celgene Corporation Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.9.5 Celgene Corporation Recent Developments
  • 11.10 Eli Lilly
    • 11.10.1 Eli Lilly Company Details
    • 11.10.2 Eli Lilly Business Overview
    • 11.10.3 Eli Lilly Bone Cancer Treatment Introduction
    • 11.10.4 Eli Lilly Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.10.5 Eli Lilly Recent Developments
  • 11.11 Roche
    • 11.11.1 Roche Company Details
    • 11.11.2 Roche Business Overview
    • 11.11.3 Roche Bone Cancer Treatment Introduction
    • 11.11.4 Roche Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.11.5 Roche Recent Developments
  • 11.12 GlaxoSmithKline
    • 11.12.1 GlaxoSmithKline Company Details
    • 11.12.2 GlaxoSmithKline Business Overview
    • 11.12.3 GlaxoSmithKline Bone Cancer Treatment Introduction
    • 11.12.4 GlaxoSmithKline Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.12.5 GlaxoSmithKline Recent Developments
  • 11.13 Sanofi
    • 11.13.1 Sanofi Company Details
    • 11.13.2 Sanofi Business Overview
    • 11.13.3 Sanofi Bone Cancer Treatment Introduction
    • 11.13.4 Sanofi Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.13.5 Sanofi Recent Developments
  • 11.14 Amneal Pharmaceuticals LLC
    • 11.14.1 Amneal Pharmaceuticals LLC Company Details
    • 11.14.2 Amneal Pharmaceuticals LLC Business Overview
    • 11.14.3 Amneal Pharmaceuticals LLC Bone Cancer Treatment Introduction
    • 11.14.4 Amneal Pharmaceuticals LLC Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.14.5 Amneal Pharmaceuticals LLC Recent Developments
  • 11.15 Baxter International
    • 11.15.1 Baxter International Company Details
    • 11.15.2 Baxter International Business Overview
    • 11.15.3 Baxter International Bone Cancer Treatment Introduction
    • 11.15.4 Baxter International Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.15.5 Baxter International Recent Developments
  • 11.16 BoehringerIngelheim
    • 11.16.1 BoehringerIngelheim Company Details
    • 11.16.2 BoehringerIngelheim Business Overview
    • 11.16.3 BoehringerIngelheim Bone Cancer Treatment Introduction
    • 11.16.4 BoehringerIngelheim Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.16.5 BoehringerIngelheim Recent Developments
  • 11.17 Fresenius Kabi
    • 11.17.1 Fresenius Kabi Company Details
    • 11.17.2 Fresenius Kabi Business Overview
    • 11.17.3 Fresenius Kabi Bone Cancer Treatment Introduction
    • 11.17.4 Fresenius Kabi Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.17.5 Fresenius Kabi Recent Developments
  • 11.18 Jubilant Cadista Pharmaceuticals
    • 11.18.1 Jubilant Cadista Pharmaceuticals Company Details
    • 11.18.2 Jubilant Cadista Pharmaceuticals Business Overview
    • 11.18.3 Jubilant Cadista Pharmaceuticals Bone Cancer Treatment Introduction
    • 11.18.4 Jubilant Cadista Pharmaceuticals Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.18.5 Jubilant Cadista Pharmaceuticals Recent Developments
  • 11.19 Mylan Pharmaceuticals
    • 11.19.1 Mylan Pharmaceuticals Company Details
    • 11.19.2 Mylan Pharmaceuticals Business Overview
    • 11.19.3 Mylan Pharmaceuticals Bone Cancer Treatment Introduction
    • 11.19.4 Mylan Pharmaceuticals Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.19.5 Mylan Pharmaceuticals Recent Developments
  • 11.20 Perrigo Company
    • 11.20.1 Perrigo Company Company Details
    • 11.20.2 Perrigo Company Business Overview
    • 11.20.3 Perrigo Company Bone Cancer Treatment Introduction
    • 11.20.4 Perrigo Company Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.20.5 Perrigo Company Recent Developments
  • 11.21 Roxane Laboratories
    • 11.21.1 Roxane Laboratories Company Details
    • 11.21.2 Roxane Laboratories Business Overview
    • 11.21.3 Roxane Laboratories Bone Cancer Treatment Introduction
    • 11.21.4 Roxane Laboratories Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.21.5 Roxane Laboratories Recent Developments
  • 11.22 Sandoz
    • 11.22.1 Sandoz Company Details
    • 11.22.2 Sandoz Business Overview
    • 11.22.3 Sandoz Bone Cancer Treatment Introduction
    • 11.22.4 Sandoz Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.22.5 Sandoz Recent Developments
  • 11.23 Henlius Biotech
    • 11.23.1 Henlius Biotech Company Details
    • 11.23.2 Henlius Biotech Business Overview
    • 11.23.3 Henlius Biotech Bone Cancer Treatment Introduction
    • 11.23.4 Henlius Biotech Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.23.5 Henlius Biotech Recent Developments
  • 11.24 Teva Pharmaceuticals USA
    • 11.24.1 Teva Pharmaceuticals USA Company Details
    • 11.24.2 Teva Pharmaceuticals USA Business Overview
    • 11.24.3 Teva Pharmaceuticals USA Bone Cancer Treatment Introduction
    • 11.24.4 Teva Pharmaceuticals USA Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.24.5 Teva Pharmaceuticals USA Recent Developments
  • 11.25 West-Ward Pharmaceuticals
    • 11.25.1 West-Ward Pharmaceuticals Company Details
    • 11.25.2 West-Ward Pharmaceuticals Business Overview
    • 11.25.3 West-Ward Pharmaceuticals Bone Cancer Treatment Introduction
    • 11.25.4 West-Ward Pharmaceuticals Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.25.5 West-Ward Pharmaceuticals Recent Developments
  • 11.26 Zydus Pharmaceuticals (Cadila Healthcare)
    • 11.26.1 Zydus Pharmaceuticals (Cadila Healthcare) Company Details
    • 11.26.2 Zydus Pharmaceuticals (Cadila Healthcare) Business Overview
    • 11.26.3 Zydus Pharmaceuticals (Cadila Healthcare) Bone Cancer Treatment Introduction
    • 11.26.4 Zydus Pharmaceuticals (Cadila Healthcare) Revenue in Bone Cancer Treatment Business (2017-2022)
    • 11.26.5 Zydus Pharmaceuticals (Cadila Healthcare) Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer